This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Other segment encompasses the distribution of pharmaceutical products and the company’s agribusiness initiatives, reflecting Nava’s strategic diversification into healthcare and agriculture. A mining concessionaire is a government-issued license or lease that gives the company exclusive rights to operate in a specific mining zone.
However, the Pharma index bucked the trend and posted gains, led by a significant rally in Glenmark Pharmaceuticals after a favourable licensing agreement. Investors must therefore exercise due caution while investing or trading in stocks. Please consult your investmentadvisor before investing.
Stocks like Glenmark Pharmaceuticals, Alkem Laboratories, and Ajanta Pharma led the sector with gains exceeding 1%. Glenmark Pharmaceuticals rose 14.55% on Friday, post the announcement that its subsidiary, IGI Therapeutics SA & AbbVie, got an exclusive global licensing agreement for the cancer and autoimmune drug ISB 2001.
Synopsis: Namita Thapar-backed Emcure Pharmaceuticals Ltd reported a resilient Q1FY26 performance, with net profit rising 9.1 Emcure Pharmaceuticals Ltd , with a market cap of Rs. We continue to augment our portfolio in all our focus markets though in-licensing and in-house development. percent QoQ and 40.5 percent YoY to Rs.
Synopsis: Lupin Limited has entered a $50 million licensing and supply agreement with Zentiva to commercialize its biosimilar Certolizumab Pegol across global markets. One of India’s most trusted pharmaceutical names has just taken a major step to deepen its international presence. The stock opened today at Rs. What’s the news?
This year, cross border activity has focused on the pharmaceutical sector as well as metals and mining. Securities and advisory services offered through LPL Financial (LPL), a registered investmentadvisor and broker-dealer (member FINRA/SIPC). Insurance products are offered through LPL or its licensed affiliates.
So, Brian is not a stranger to me, and we have some shared financial interests, but the reason I wanted to bring him in here is there are few people in the industry who have a better perch by which to look at the world of registered investmentadvisors, broker-dealers, all of the changes that are taking place in the space.
I do believe it should be different regulated differently from portfolio management, which is the typical definition of the registered investmentadvisor, but that it shouldn’t be the CFP Board that is controlling the regulatory environment for financial planners. Salaske: What is an investmentadvisor?
We organize all of the trending information in your field so you don't have to. Join 36,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content